Every material Form 8-K SelectQuote, Inc. has filed with the SEC since May 05, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
SelectQuote reported first-quarter fiscal 2027 results for the period ended September 30, 2026, with revenue down from $328.8 million a year earlier while its net loss and adjusted EBITDA improved. The company reiterated its full-year fiscal 2027 targets, including revenue of $1.35 billion to $1.45 billion and adjusted EBITDA of $90 million to $115 million. Shareholders get a mixed picture: the top line shrank, but the company is losing less money and has not changed its outlook.
Revenue was $280.0 million, down from $328.8 million in the year-earlier quarter.
Net loss was $20.3 million, compared with $30.5 million a year earlier; adjusted EBITDA was $(17.0) million, compared with $(32.1) million.
Fiscal 2027 guidance was reiterated: revenue of $1.35 billion to $1.45 billion, adjusted EBITDA of $90 million to $115 million, and operating cash flow of more than $60 million.
SelectRx members totaled 99,753 as of September 30, 2026, down 7% from 106,914 a year earlier.
SelectQuote reported fourth-quarter fiscal 2026 revenue of $321.7 million, down from $345.1 million a year earlier, and a net loss of $16.8 million, compared with net income of $12.9 million in the prior-year quarter. Adjusted EBITDA rose to $11.9 million from $2.7 million, and cash used in operations narrowed to $3.3 million from $37.5 million. The company also gave fiscal 2027 guidance of $1.35 billion to $1.45 billion in revenue and $90 million to $115 million in Adjusted EBITDA.
Q4 fiscal 2026 revenue was $321.7 million versus $345.1 million in Q4 fiscal 2025; net loss was $16.8 million versus net income of $12.9 million
Q4 Adjusted EBITDA was $11.9 million versus $2.7 million a year earlier; fiscal 2026 Adjusted EBITDA was $109.1 million versus $126.3 million
Fiscal 2026 net income was $62.2 million and operating cash flow was $31.9 million, a $44 million improvement over fiscal 2025
Fiscal 2027 guidance: revenue of $1.35 billion to $1.45 billion, Adjusted EBITDA of $90 million to $115 million, and operating cash flow of more than $60 million
SelectQuote reported fiscal third-quarter 2026 results for the quarter ended March 31, 2026, with revenue of $430.9 million, up from $408.2 million a year earlier, and net income of $40.2 million, up from $26.0 million. The company reaffirmed its fiscal 2026 guidance, which keeps its revenue and Adjusted EBITDA outlook unchanged for shareholders.
Q3 revenue of $430.9 million vs. $408.2 million in the prior-year quarter; Adjusted EBITDA of $44.6 million vs. $37.7 million.
Net income of $40.2 million vs. $26.0 million; net income attributable to common shareholders was $21.4 million.
Fiscal 2026 guidance reaffirmed: revenue of $1.61 billion to $1.71 billion and Adjusted EBITDA of $90 million to $100 million.
Nine-month Senior segment revenue fell 3%, while Healthcare Services revenue rose 23%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every SelectQuote, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →